| Description |
Publish Date |
LINKS |
| Cabotegravir Patient appointment reminder card |
01/08/2024 |
 |
| Cabotegravir Patient educational brochure |
01/08/2024 |
|
| Cabotegravir Provider checklist |
01/08/2024 |
|
| Cabotegravir Provider educational brochure |
01/08/2024 |
|
| Tafenoquine: A radical cure for P. vivax malaria |
10/01/2025 |
|
| Important safety information on Dolutegravir in Myanmar (Safety Notification_Korean label update for Dolutegravir containing products) |
01-11-2023 |
|
| Important safety information on Hepatitis B surface antigen recombinant vaccine in Myanmar (Initial Safety Notification Engerix-B and Myelitis_November 2023) |
17-11-2023 |
|
| Important safety information on Hepatitis B surface antigen recombinant vaccine in Myanmar (Updated Safety Notification Engerix-B and Myelitis_December 2023) |
02-01-2024 |
|
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates |
18/12/2023 |
|
Important safety information on Hepatitis B surface antigen recombinant vaccine (Updated Safety Notification Engerix-B and Myelitis_January 2024) |
08/01/2024 |
|
Important safety information on Hepatitis B surface antigen recombinant vaccine - Updated Safety Notification Engerix-B and Myelitis_May 2024 |
07/05/2024 |
|
